Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
115.00    3.50 (3.14%)
Bid:
112.00
Ask:
118.00
Spread: 6.00 (5.357%)
Market Cap: £69.19m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

PDMR Shareholding

29 Jun 2018 16:59

RNS Number : 1434T
Intercede Group PLC
29 June 2018
 

 

 

 

29 June 2018

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

Director/PDMR shareholdings

 

 

Intercede, the software and service company specialising in identity, credential management and secure mobility, was notified on 29 June 2018 of the following transactions in its ordinary shares of 1 pence ("Ordinary Shares"): 

 

- on 28 June 2018, Richard Parris, Non-Executive Director of the Company, transferred, via sale and purchase, 68,000 Ordinary Shares. He sold 68,000 Ordinary Shares at a price of 29 pence per Ordinary Share from an account in his own name and bought 68,000 Ordinary Shares at a price of 29.02 pence per Ordinary Share to be held in his ISA;

 

- on 28 June 2018, Jayne Murphy, a person closely associated ("PCA") with Richard Parris, Non-Executive Director of the Company, transferred, via sale and purchase, 68,000 Ordinary Shares. She sold 68,000 Ordinary Shares at a price of 29 pence per Ordinary Share from an account in her own name and bought 68,000 Ordinary Shares at a price of 29.02 pence per Ordinary Share to be held in her ISA; and

 

- on 28 June 2018, Jayne Murphy, a ("PCA") with Richard Parris, Non-Executive Director of the Company, sold 10,000 Ordinary Shares at a price of 29 pence per Ordinary Share.

 

- Following these transactions, Richard Parris and PCA's with him are beneficially interested in 5,703,552 Ordinary Shares, representing 11.3% of the Company's issued share capital.

 

ENQUIRIES

 

Intercede Group plc Tel. +44 (0)1455 558 111

Klaas van der Leest, Chief Executive

Andrew Walker, Finance Director

 

finnCap Tel. +44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Simon Hicks, Corporate Finance

 

 

About Intercede

 

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

 

For more information visit: www.intercede.com

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Parris - Non-Executive Director

Jayne Murphy - PCA of Richard Parris

2.

Reason for the Notification

a)

Position/status

See 1(a) above

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Intercede Group plc

b)

LEI

213800VFMNCYCDQ65C90

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence

Identification code

GB0003287249

b)

Nature of the transactions

1. Richard Parris - transfer via sale of 68,000 ordinary shares at 29p per ordinary share and purchase of 68,000 ordinary shares at 29.02p per ordinary share from Mr Parris's own name to his ISA

 

2. Jayne Murphy - transfer via sale of 68,000 ordinary shares at 29p per ordinary share and purchase of 68,000 ordinary shares at 29.02p per ordinary share from Mrs Murphy's own name to her ISA

 

3. Jayne Murphy - sale of ordinary shares

c)

Price(s) and volume(s)

1. Richard Parris

Price(s)

Volume(s)

Sold

29p

 

Bought:

29.02p

 

68,000

 

 

68,000

 

2. Jayne Murphy

Price(s)

Volume(s)

Sold

29p

 

Bought:

29.02p

 

68,000

 

 

68,000

 

3. Jayne Murphy

Price(s)

Volume(s)

Sold

29p

 

10,000

d)

Aggregated information:

· Aggregated volumes

· Prices

See 4(c) above

e)

Date of the transactions

28 June 2018

f)

Place of the transactions

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKMGZVKLMGRZM
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report
26th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.